edoxaban: Clinical Trials

35 trials of edoxaban, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 5 unknown, 3 not yet recruiting, 3 recruiting. 35 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 335Completed 22, Unknown 5, Not yet recruiting 3, Recruiting 3, Terminated 2
Phase 24Unknown 2, Completed 1, Not yet recruiting 1

Follow edoxaban: new trials by email Literature Review of edoxaban trials Research Report on edoxaban

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
Edoxaban 15 mg, Aspirin or clopidogrel - Stroke, Ischemic
Phase 3RecruitingSunnybrook Health Sciences Centre12042026-11-012026-10-23
Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy
Rivaroxaban, or Edoxaban , or Apixaban , or Dabigatran, Aspirin - Stroke, Acute Ischemic Stroke
Phase 3Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine6802026-08-152026-08-05
Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
edoxaban, Edoxaban 30 mg - Elderly, Atrial Fibrillation (AF)
Phase 2 / Phase 3Not yet recruitingNational Taiwan University Hospital3002025-04-012025-04-02
Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
Direct-Acting Oral Anticoagulants (used as per local standard practice) - Traumatic Intracranial Haemorrhage
Phase 3RecruitingWalton Centre NHS Foundation Trust10842025-03-102026-06-18
Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
Edoxaban - Thrombosis, Venous, Cancer
Phase 3Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences3662023-11-302023-11-29
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
Acetylsalicylic acid, Apixaban, Rivaroxaban - Aortic Stenosis
Phase 3CompletedOslo University Hospital3602021-12-042026-06-09
Effects of Edoxaban on Platelet Aggregation
ASA, Clopidogrel, Edoxaban - SCAD, AMI
Phase 2 / Phase 3CompletedUniversity of Sao Paulo612021-09-142025-04-27
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
DOAC, VKA - Bleeding Post Cardiac Surgery, Indication for Anticoagulation
Phase 3RecruitingPopulation Health Research Institute35002021-07-182026-09-18
Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage
Apixaban - Anticoagulants; Increased
Phase 3UnknownUniversity of Texas at Austin1002021-07-012021-05-19
Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)
Edoxaban, Warfarin Potassium, Warfarin Potassium placebo - CTEPH
Phase 3CompletedKyushu University742021-03-232023-10-05
CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
Edoxaban Tablets, Colchicine Tablets - SARS-CoV Infection, COVID-19
Phase 3TerminatedInsel Gruppe AG, University Hospital Bern602021-01-212022-09-08
Hamburg Edoxaban for Anticoagulation in COVID-19 Study
Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or Placebo - Covid19
Phase 3CompletedUniversitätsklinikum Hamburg-Eppendorf1402020-11-122023-05-23
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention
Dabigatran, Apixaban, Edoxaban - Stroke, Ischemic
Phase 3UnknownUniversity of Zurich6202019-12-052023-08-16
Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation
Edoxaban - Aortic Valve Stenosis
Phase 3UnknownErasmus Medical Center1002019-08-012022-07-27
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
Apixaban Oral Tablet, Dabigatran, Edoxaban Tablets - Atrial Fibrillation, Intracerebral Hemorrhage
Phase 3CompletedImperial College London3192019-06-032025-01-13
Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)
Edoxaban, Enoxaparin - Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
Phase 2 / Phase 3UnknownSamsung Medical Center402018-06-152018-06-26
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
Edoxaban, Standard of Care (SOC) - Cardiac Disease
Phase 3CompletedDaiichi Sankyo1682018-05-152022-07-26
Start or STop Anticoagulants Randomised Trial (SoSTART)
Apixaban, Rivaroxaban, Edoxaban - Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive
Phase 3CompletedUniversity of Edinburgh2032018-03-282022-04-08
Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)
Edoxaban, Warfarin, parenteral anti-coagulant (UFH) - MV(Mitral Valve) Repair
Phase 3CompletedYonsei University2202017-12-012020-01-02
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Edoxaban, Standard of Care - Venous Thromboembolism (VTE), Pulmonary Embolism
Phase 3CompletedDaiichi Sankyo2902017-03-272025-02-28

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Atrial Fibrillation (11)  ·  Venous Thromboembolism (7)  ·  Venous Thrombosis (7)  ·  Thrombosis (5)  ·  Ischemic Stroke (4)  ·  Stroke (4)  ·  Thromboembolism (4)  ·  Embolism (3)  ·  Pulmonary Embolism (3)  ·  Aortic Valve Stenosis (2)  ·  COVID-19 (2)  ·  Embolism and Thrombosis (2)  ·  Heart Diseases (2)  ·  Hemostatic Disorders (2)  ·  Intracranial Hemorrhages (2)

Sponsors

Daiichi Sankyo (7)  ·  Daiichi Sankyo Co., Ltd. (6)  ·  Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2)  ·  Atrial Fibrillation Network (1)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Erasmus Medical Center (1)  ·  Imperial College London (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Kyushu University (1)  ·  National Taiwan University Hospital (1)  ·  Oslo University Hospital (1)  ·  Population Health Research Institute (1)  ·  Samsung Medical Center (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

United Kingdom (12)  ·  Germany (11)  ·  Spain (11)  ·  France (10)  ·  Italy (10)  ·  Japan (10)  ·  Belgium (9)  ·  Hungary (9)  ·  Netherlands (9)  ·  Canada (8)  ·  South Korea (8)  ·  Austria (7)  ·  Poland (7)  ·  Taiwan (7)  ·  Ukraine (7)

Top investigators

Takeshi Fuji (3)  ·  Andreas Gotte, Prof., MD (1)  ·  Catherine McMahon (1)  ·  Emilie Belley-Cote, MD, MSc (1)  ·  Gang Zhao, M.D. (1)  ·  Kohtaro Abe (1)  ·  Min Lou, PhD, MD (1)  ·  Mira Katan, Prof.Dr.med. (1)  ·  Nicolas M Van Mieghem, MD, PhD (1)  ·  Pascal Vranckx, MD (1)  ·  Paulus Kirchhof, Prof. Dr. (1)  ·  Roland E Veltkamp, FESO (1)  ·  Rustam Al-Shahi Salman, MA PhD FRCP (1)

Results publications

PMID 36700520, PMID 27980462, PMID 34022170, PMID 40925065, PMID 20934556, PMID 21861537, PMID 22398655, PMID 23991658, PMID 24251359, PMID 24302269, PMID 24680549, PMID 24947287, PMID 25104527, PMID 25294589, PMID 25653574, PMID 25769357, PMID 25769361, PMID 25965706, PMID 26179767, PMID 26271200, PMID 26908401, PMID 27207971, PMID 27284271, PMID 27358434, PMID 27387994, PMID 27402235, PMID 27476789, PMID 27570090, PMID 27590218, PMID 27609678, PMID 27706467, PMID 28077507, PMID 28302288, PMID 28666993, PMID 28689179, PMID 28862934, PMID 29231094, PMID 29248859, PMID 29421002, PMID 29663464, PMID 29748353, PMID 29947751, PMID 29967197, PMID 30172099, PMID 30236308, PMID 30586727, PMID 31492505, PMID 31597460, PMID 31777160, PMID 31986264

NIH funding

2016 (5), 2014 (1), 2015 (1), 2017 (1), 2018 (1)